Cognition Disorder

Over 25 million people globally will be living with Parkinsons’ disease by 2050, according to a new analysis published in BMJ.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

Speed of processing training reduced the risk for future falls over 10 years in high-risk older adults, while reasoning and memory training did not reduce the likelihood of future falls in this population, according to research.

Alzheon Inc. has announced positive interim findings from an ongoing phase 2 study evaluating ALZ-801, an investigational disease-modifying treatment for Alzheimer’s disease.

In 2019, more than 67 million adults in the U.S. reported having a disability, a 1% increase since the prevalence was last examined in 2016, according to findings published in JAMA Network Open.